Scientists at Boston Children’s Hospital and Northeastern University have developed a CRISPR genome editing system that suppresses the growth of triple-negative breast cancer (TNBC). A ...
CRISPR gene editing technique can help stop the progression of triple-negative breast cancer. A new CRISPR nanotherapeutic discovered knocks out a breast cancer oncogene, called Lipocalin 2 (Lcn2) in ...
Simultaneous epigenetic editing of three genes in primary human T cells resulted in no indels or genomic alterations, while simultaneous triple editing with a Cas9 nuclease generated significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback